Guidelines for the secondary prevention of ischaemic heart disease
... Beta-blockers rarely exacerbate intermittent claudication and therefore should be prescribed if at all possible. 15 patients with a 6% annual risk of coronary heart disease need to be treated for one year with a beta-blocker to prevent one event. The practice uses atenolol as the first choice beta-b ...
... Beta-blockers rarely exacerbate intermittent claudication and therefore should be prescribed if at all possible. 15 patients with a 6% annual risk of coronary heart disease need to be treated for one year with a beta-blocker to prevent one event. The practice uses atenolol as the first choice beta-b ...
Clinical Implications of cTnI Elevation Curve following Primary
... Background: Cardiac troponin release pattern after thrombolytic therapy for acute myocardial infarction was found to be a reliable predictor for infarct size and post‐infarct complications and prognosis. We previously described the release kinetics of troponin after primary percutaneous coronary ...
... Background: Cardiac troponin release pattern after thrombolytic therapy for acute myocardial infarction was found to be a reliable predictor for infarct size and post‐infarct complications and prognosis. We previously described the release kinetics of troponin after primary percutaneous coronary ...
Surgical treatment of congenital coronary artery
... of the heart, often without CPB. A congenital coronary artery fistula to the left ventricle was closed by ligation during CBP.[1] ...
... of the heart, often without CPB. A congenital coronary artery fistula to the left ventricle was closed by ligation during CBP.[1] ...
A Patient`s Guide to Primary and Secondary Prevention
... antiplatelet agents. They work by reducing the “stickiness” of platelets, the blood cells most responsible for forming blood clots. By reducing platelet “stickiness,” the drugs make platelets less able to stick together to form blood clots. Aspirin was the first, and still widely used, antiplatelet ...
... antiplatelet agents. They work by reducing the “stickiness” of platelets, the blood cells most responsible for forming blood clots. By reducing platelet “stickiness,” the drugs make platelets less able to stick together to form blood clots. Aspirin was the first, and still widely used, antiplatelet ...
Three-Dimensional Coronary Angiography
... 3. Chen SY, Carroll JD, Messenger JC. Quantitative analysis of reconstructed 3D coronary arterial tree and intracoronary devices. IEEE Trans Med Imag. 2002;21:724-740. 4. Chen SJ, Hoffmann KR, Carroll JD. Three-dimensional reconstruction of coronary arterial tree based on biplane angiograms. SPIE. M ...
... 3. Chen SY, Carroll JD, Messenger JC. Quantitative analysis of reconstructed 3D coronary arterial tree and intracoronary devices. IEEE Trans Med Imag. 2002;21:724-740. 4. Chen SJ, Hoffmann KR, Carroll JD. Three-dimensional reconstruction of coronary arterial tree based on biplane angiograms. SPIE. M ...
Acute Coronary Syndromes
... has traditionally been the mainstay of therapy in acute coronary syndromes as its efficacy has been documented in several large, randomized trials ...
... has traditionally been the mainstay of therapy in acute coronary syndromes as its efficacy has been documented in several large, randomized trials ...
Focus on Vastarel MR - Heart and Metabolism
... an increase in the amount of ATP available to ensure correct cardiac function [11]. Many trials in patients with stable angina had already demonstrated the clinical efficacy of trimetazidine 20 mg, either in monotherapy [12] or in combination with other drugs [13], compared with placebo [14] or othe ...
... an increase in the amount of ATP available to ensure correct cardiac function [11]. Many trials in patients with stable angina had already demonstrated the clinical efficacy of trimetazidine 20 mg, either in monotherapy [12] or in combination with other drugs [13], compared with placebo [14] or othe ...
16-Heart
... Medium sized, passes near its termination into the posterior interventricular groove to end in a poor anastomosis with the termination of the anterior interventricular artery, from the left coronary artery. 3- Small twigs to the ascending aorta and pulmonary trunk. 4- A branch to the S.A. node, whic ...
... Medium sized, passes near its termination into the posterior interventricular groove to end in a poor anastomosis with the termination of the anterior interventricular artery, from the left coronary artery. 3- Small twigs to the ascending aorta and pulmonary trunk. 4- A branch to the S.A. node, whic ...
A rare case: Coronary sinus thrombosis
... CST is a rare acquired anomaly of the coronary sinus. It has been reported only as a complication of cardiac transplantation and right heart catheterization in non infected patients. In cardiac procedures that use access to the right atrium, such as insertion of central venous lines, pacing wire, co ...
... CST is a rare acquired anomaly of the coronary sinus. It has been reported only as a complication of cardiac transplantation and right heart catheterization in non infected patients. In cardiac procedures that use access to the right atrium, such as insertion of central venous lines, pacing wire, co ...
presentation source
... Nitrates - reduce venous and intra cardiac pressures, dilate coronary arteries and reduce impedance to emptying left ventricle ...
... Nitrates - reduce venous and intra cardiac pressures, dilate coronary arteries and reduce impedance to emptying left ventricle ...
right atrial thrombus, aortic regurgitation, coronary artery stenosis
... increase the risk for thrombo- embolic complications, mainly cerebrovascular, posed by valve lesions. Superadded bacterial endocarditis is rare. ...
... increase the risk for thrombo- embolic complications, mainly cerebrovascular, posed by valve lesions. Superadded bacterial endocarditis is rare. ...
Long-term survival in patients with coronary artery disease
... function, number of diseased coronary arteries, involvement of the left main coronary artery . advanced age. severity of angina, hypertension and others. However, the European prospective randomized study (6) of patients with coronary artery disease suggested that peripheral arterial disease might h ...
... function, number of diseased coronary arteries, involvement of the left main coronary artery . advanced age. severity of angina, hypertension and others. However, the European prospective randomized study (6) of patients with coronary artery disease suggested that peripheral arterial disease might h ...
Acute Inferior Myocardial Infarction
... are present, or if spasm is a component of coronary occlusion. Efforts should also be made to decrease myocardial oxygen demand by use of a beta-blocker. ...
... are present, or if spasm is a component of coronary occlusion. Efforts should also be made to decrease myocardial oxygen demand by use of a beta-blocker. ...
Postoperative rate induced left bundle branch block after craniotomy
... induced LBBB which manifests when the heart rate increases to a particular number. The other one is deceleration induced where LBBB is seen when the heart rate drops to a particular number.[1] The possible causes of such LBBB could be structural heart disease (cardiomyopathy, congenital heart diseas ...
... induced LBBB which manifests when the heart rate increases to a particular number. The other one is deceleration induced where LBBB is seen when the heart rate drops to a particular number.[1] The possible causes of such LBBB could be structural heart disease (cardiomyopathy, congenital heart diseas ...
Acute coronary Syndromes: An Interactive, Evidence Based
... ACE inhibitor within 24 hours with pulmonary congestion or LVEF < 40% in the absence of hypotension or contraindication Because of the increased risk of mortality, reinfarction, HTN, CHF, and myocardial rupture NSAIDS except for ASA should be discontinued at presentation Class II indications: It ...
... ACE inhibitor within 24 hours with pulmonary congestion or LVEF < 40% in the absence of hypotension or contraindication Because of the increased risk of mortality, reinfarction, HTN, CHF, and myocardial rupture NSAIDS except for ASA should be discontinued at presentation Class II indications: It ...
20-ischemic-heart-disease
... absence of myocardial damage. MI symptoms occur at rest and there is evidence of myocardial damage, demonstrated by increased level of cardiac Troponin or creatinine kinase-MB. IMPORTANT – Troponin is more specific ...
... absence of myocardial damage. MI symptoms occur at rest and there is evidence of myocardial damage, demonstrated by increased level of cardiac Troponin or creatinine kinase-MB. IMPORTANT – Troponin is more specific ...
Showing record 1 from the 1 matches found. Article Reference No
... fondaparinux patients were found to have about half the rate of major bleeding 9 days after randomization and at least as good clinical outcomes (death, myocardial infarction, major bleeding and stroke) after 6 months of follow-up. To undertake the economic evaluation, health care resource use and c ...
... fondaparinux patients were found to have about half the rate of major bleeding 9 days after randomization and at least as good clinical outcomes (death, myocardial infarction, major bleeding and stroke) after 6 months of follow-up. To undertake the economic evaluation, health care resource use and c ...
Coronary Embolism: Review of the Literature and
... systolic aortic murmur fifteen years prior to hospitalization. No history of rheumatic fever was elicited. The patient had been in good health except for occasional attacks of precordial pain which had become more severe and had occurred oftener within the last two years. On December 14, 1947, while ...
... systolic aortic murmur fifteen years prior to hospitalization. No history of rheumatic fever was elicited. The patient had been in good health except for occasional attacks of precordial pain which had become more severe and had occurred oftener within the last two years. On December 14, 1947, while ...
Definition of Living Care Plus Coverage
... Early Cancer Carcinoma in situ of the following sites: breast, uterus, ovary, fallopian tube, vulva, vagina, cervix uteri, colon, rectum, penis, testis, lung, liver, stomach, nasopharynx or bladder. Carcinoma in situ means the focal autonomous new growth of carcinomatous cells confined to the cells ...
... Early Cancer Carcinoma in situ of the following sites: breast, uterus, ovary, fallopian tube, vulva, vagina, cervix uteri, colon, rectum, penis, testis, lung, liver, stomach, nasopharynx or bladder. Carcinoma in situ means the focal autonomous new growth of carcinomatous cells confined to the cells ...
Cardiogenic Shock - American Heart Association
... • Multivessel Coronary Artery Disease • Prior STEMI or Angina • STEMI with new LBBB • History of Heart Failure ...
... • Multivessel Coronary Artery Disease • Prior STEMI or Angina • STEMI with new LBBB • History of Heart Failure ...
Document
... symptoms and increased survival. Therefore, explaining the spectrum of symptoms from death during infancy to survival into adulthood.7 Clinical presentation is often non-specific ranging from angina, syncope, arrhythmias, exertional fatigue to nocturnal dyspnoea. A review found 66% of patients had s ...
... symptoms and increased survival. Therefore, explaining the spectrum of symptoms from death during infancy to survival into adulthood.7 Clinical presentation is often non-specific ranging from angina, syncope, arrhythmias, exertional fatigue to nocturnal dyspnoea. A review found 66% of patients had s ...
Lecture 3
... Ischemic Heart Disease Myocardial infarction • The severity or duration of ischemia is enough to cause cardiac muscle death. • Typically results from acute thromboses that ...
... Ischemic Heart Disease Myocardial infarction • The severity or duration of ischemia is enough to cause cardiac muscle death. • Typically results from acute thromboses that ...
Tako-tsubo cardiomyopathy
... patients develop Q-waves (most frequently in leads V2-V4). Within 24 to 48 hours of the acute presentation, the ECG frequently shows deeply inverted T-waves and a markedly prolonged QTinterval in both precordial and limb leads. The QTinterval prolongation often normalizes within two days, but the T- ...
... patients develop Q-waves (most frequently in leads V2-V4). Within 24 to 48 hours of the acute presentation, the ECG frequently shows deeply inverted T-waves and a markedly prolonged QTinterval in both precordial and limb leads. The QTinterval prolongation often normalizes within two days, but the T- ...
Drug-eluting stent
A drug-eluting stent (DES) is a peripheral or coronary stent (a scaffold) placed into narrowed, diseased peripheral or coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombi), could otherwise block the stented artery, a process called restenosis. The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist or interventional radiologist during an angioplasty procedure.Drug-eluting stents in current clinical use were approved by the FDA after clinical trials showed they were statistically superior to bare-metal stents for the treatment of native coronary artery narrowings, having lower rates of major adverse cardiac events (usually defined as a composite clinical endpoint of death + myocardial infarction + repeat intervention because of restenosis). The first drug-eluting stents to be approved in Europe and the U.S. were coated with paclitaxel or an mTOR inhibitor, such as sirolimus.